Pharmaceuticals Analysts Scala & Nedelcovych, along with Dr. Burstein of the Dana-Farber Cancer Institute discuss Novartis’ NATALEE Trial post positive topline results and how will it compare to the Verzenio (LLY) monarchE results on an Analyst/Industry conference call to be held on April 4 at 2 pm. Webcast Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on LLY:
- TD Cowen pharmaceuticals analysts to hold analyst/industry conference call
- Eli Lilly price target raised to $310 from $290 at Jefferies
- Lilly reports Alzheimer’s treatment reduced amyloid in small study, Reuters says
- Viking Therapeutics price target raised to $31 from $20 at BTIG
- ‘Our Best Long-Term Picks’: Morgan Stanley Suggests 3 High-Quality Stocks to Buy Now